Education
About Us
Working with TipRanks
Follow Us
Mountain Valley MD (TSE:MVMD)
:MVMD
MVMD Stock Chart & Stats
C$0.02
<C$0.01(20.00%)
At close: 4:00 PM EST
C$0.02
<C$0.01(20.00%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.04
Previous CloseN/A
Volume2.00K
Average Volume (3M)205.59K
Market Cap
C$3.52M
Enterprise ValueC$4.81M
Total Cash (Recent Filing)C$1.72M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,354,950
10 Day Avg. Volume152,980
30 Day Avg. Volume205,595
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)3.44
Price to Sales (P/S)177.77
P/FCF Ratio-2.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low / Near-zero DebtNear-zero reported debt materially lowers financial risk and interest burdens, improving flexibility to invest or restructure. Over the next 2-6 months this reduces bankruptcy risk while preserving capacity to raise equity or execute strategic partnerships without a heavy debt overhang.
Return To Positive Gross ProfitMoving to positive gross profit indicates improvements in product economics or cost of goods sold control. If sustained, this provides a foundational margin on revenue that can leverage operating spend in future periods and is a necessary step toward durable profitability.
Operates In Specialty & Generic PharmaThe specialty and generic drug sector has structural demand, regulatory barriers and recurring revenue potential. These industry characteristics create durable market opportunities for product commercialization and licensing that can support longer-term revenue growth if development succeeds.
Bears Say
Persistent Operating Cash BurnContinued negative operating and free cash flow signals ongoing cash burn and inability to self-fund operations. Over months this necessitates external financing, increasing dilution or covenant risk, and constrains R&D or commercialization investments absent clear funding plans.
Eroded Equity CushionA sharply reduced equity base weakens the company's capital buffer to absorb losses or fund growth. This erosion magnifies funding vulnerability and raises dilution risk when new capital is required, limiting strategic optionality and resilience against adverse shocks.
Minimal And Declining Revenue With Large LossesVery low, volatile revenue alongside sizable recurring losses shows weak commercial traction and poor operating leverage. Without meaningful revenue growth, the company cannot cover fixed costs, prolonging reliance on financing and undermining a credible path to sustainable profitability.
Mountain Valley MD News
MVMD FAQ
What was Mountain Valley MD’s price range in the past 12 months?
Mountain Valley MD lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Mountain Valley MD’s market cap?
Mountain Valley MD’s market cap is C$3.52M.
When is Mountain Valley MD’s upcoming earnings report date?
Mountain Valley MD’s upcoming earnings report date is Mar 04, 2026 which is in 8 days.
How were Mountain Valley MD’s earnings last quarter?
Mountain Valley MD released its earnings results on Dec 02, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Mountain Valley MD overvalued?
According to Wall Street analysts Mountain Valley MD’s price is currently Overvalued.
Does Mountain Valley MD pay dividends?
Mountain Valley MD does not currently pay dividends.
What is Mountain Valley MD’s EPS estimate?
Mountain Valley MD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mountain Valley MD have?
Mountain Valley MD has 352,354,950 shares outstanding.
What happened to Mountain Valley MD’s price movement after its last earnings report?
Mountain Valley MD reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Mountain Valley MD?
Currently, no hedge funds are holding shares in TSE:MVMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mountain Valley MD
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Technical Analysis
Ayurcann Holdings Corp.
―
Revive Therapeutics
―
PharmaCielo
―
CanadaBis Capital
―
Lobe Sciences
―
Options Prices
Currently, No data available
---